EFX vs ELDN · P/E 54, rev $5.68B vs $209.6M cap
Equifax Inc (EFX) versus Eledon Pharmaceuticals Inc (ELDN) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
Eledon Pharmaceuticals Inc (ELDN) is a biotechnology company listed on US.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
ELDN does not have a complete income-statement cache yet.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. ELDN currently screens at market cap $209.6M.
Not investment advice. Open the EFX and ELDN stock pages for the full models.
Not investment advice.